The global bioinformatics market is expanding rapidly as advancements in genomic research, precision medicine, artificial intelligence, and biological data analysis reshape the life sciences industry. The market was valued at USD 16.70 billion in 2025 and is projected to grow from USD 18.63 billion in 2026 to USD 34.41 billion by 2031, registering a CAGR of 13.1% during the forecast period.
The growing adoption of next-generation sequencing (NGS), increasing incorporation of artificial intelligence and machine learning in biological data analysis, rising investment in precision medicine and omics research, and strong demand for cloud-based bioinformatics tools are expected to support market expansion.
Growth in the bioinformatics market is also attributed to increasing R&D activities in the pharmaceutical and biotechnology sectors, expanding applications in drug discovery, biomarker detection, and clinical trials, and the growing need to manage and analyze large volumes of biological data.
Bioinformatics Market Size by Region and Country
The regional outlook indicates strong growth across North America, Europe, Asia Pacific, Latin America, and the Middle East. North America represents a significant bioinformatics market supported by advanced genomic research infrastructure, pharmaceutical R&D, and adoption of AI-powered biological data analysis. Asia Pacific is experiencing strong growth driven by increasing investments in genomics, precision medicine, healthcare digitalization, and biotechnology research.
North America Bioinformatics Market
The North America bioinformatics market was valued at USD 7,876.8 million in 2026 and is projected to reach USD 14,624.3 million by 2031, representing a CAGR of 13.2%.
North America’s bioinformatics market is positioned for sustained expansion through 2031, with the region’s growth supported by increasing investments in genomic research, advanced healthcare infrastructure, precision medicine, and AI-driven biological data analysis.
US Bioinformatics Market
The US bioinformatics market was valued at USD 7,357.9 million in 2026 and is projected to reach USD 13,592.8 million by 2031, representing a CAGR of 13.1%.
The US bioinformatics market is positioned for sustained growth through 2031, driven by technological advancements in genomic analysis, increasing prevalence of chronic diseases, and growing adoption of AI-powered diagnostic tools.
Canada Bioinformatics Market
The Canada bioinformatics market was valued at USD 518.9 million in 2026 and is projected to reach USD 1,031.5 million by 2031, representing a CAGR of 14.7%.
Canada’s bioinformatics market is poised for sustained expansion, driven by increasing investments in healthcare innovation and genomic research infrastructure.
Europe Bioinformatics Market
The Europe bioinformatics market was valued at USD 5,562.3 million in 2026 and is projected to reach USD 10,071.8 million by 2031, representing a CAGR of 12.6%.
Europe’s bioinformatics market is poised for sustained expansion, driven by increasing investments in genomic research, personalized medicine initiatives, and digital health transformation across the region.
| Market | 2026 Value | 2031 Value | CAGR |
|---|---|---|---|
| Europe | USD 5,562.3 Million | USD 10,071.8 Million | 12.6% |
| Germany | USD 1,577.3 Million | USD 2,870.3 Million | 12.7% |
| UK | USD 1,224.6 Million | USD 2,365.3 Million | 14.1% |
| France | USD 864.7 Million | USD 1,629.4 Million | 13.5% |
| Italy | USD 516.0 Million | USD 857.5 Million | 10.7% |
| Spain | USD 392.5 Million | USD 675.9 Million | 11.5% |
| Rest of Europe | USD 987.2 Million | USD 1,673.4 Million | 11.1% |
Germany Bioinformatics Market
The Germany bioinformatics market was valued at USD 1,577.3 million in 2026 and is projected to reach USD 2,870.3 million by 2031, representing a CAGR of 12.7%.
Germany’s bioinformatics market is positioned for sustained expansion through 2031, driven by the country’s established strengths in pharmaceutical research, biotechnology innovation, and healthcare infrastructure.
UK Bioinformatics Market
The UK bioinformatics market was valued at USD 1,224.6 million in 2026 and is projected to reach USD 2,365.3 million by 2031, representing a CAGR of 14.1%.
The UK bioinformatics market is poised for substantial expansion, growing from USD 1,224.6 million in 2026 to USD 2,365.3 million by 2031.
France Bioinformatics Market
The France bioinformatics market was valued at USD 864.7 million in 2026 and is projected to reach USD 1,629.4 million by 2031, representing a CAGR of 13.5%.
France’s bioinformatics market is positioned for sustained expansion, driven by increasing investments in genomic research, personalized medicine initiatives, and the country’s commitment to digital health transformation.
Italy Bioinformatics Market
The Italy bioinformatics market was valued at USD 516.0 million in 2026 and is projected to reach USD 857.5 million by 2031, representing a CAGR of 10.7%.
Italy’s bioinformatics market is positioned for sustained growth as the country strengthens its position in genomic research and personalized medicine.
Spain Bioinformatics Market
The Spain bioinformatics market was valued at USD 392.5 million in 2026 and is projected to reach USD 675.9 million by 2031, representing a CAGR of 11.5%.
Spain’s bioinformatics market is poised for sustained expansion, driven by government support for genomic research, increasing adoption of personalized medicine frameworks, and digital transformation across Spanish healthcare systems.
Rest of Europe Bioinformatics Market
The Rest of Europe bioinformatics market was valued at USD 987.2 million in 2026 and is projected to reach USD 1,673.4 million by 2031, representing a CAGR of 11.1%.
Rest of Europe’s bioinformatics market is positioned for sustained growth, expanding from USD 987.2 million in 2026 to USD 1,673.4 million by 2031.
Asia Pacific Bioinformatics Market
The Asia Pacific bioinformatics market was valued at USD 3,667.5 million in 2026 and is projected to reach USD 7,120.8 million by 2031, representing a CAGR of 14.2%.
The Asia Pacific bioinformatics market is positioned for exceptional growth through 2031, driven by substantial investments in genomic research infrastructure, government initiatives supporting precision medicine, and rapid digital transformation across healthcare systems.
| Market | 2026 Value | 2031 Value | CAGR |
|---|---|---|---|
| Asia Pacific | USD 3,667.5 Million | USD 7,120.8 Million | 14.2% |
| China | USD 1,193.8 Million | USD 2,400.2 Million | 15.0% |
| Japan | USD 823.2 Million | USD 1,606.3 Million | 14.3% |
| India | USD 568.3 Million | USD 1,177.0 Million | 15.7% |
| South Korea | USD 277.9 Million | USD 518.3 Million | 13.3% |
| Australia | USD 342.3 Million | USD 619.4 Million | 12.6% |
| Rest of Asia Pacific | USD 462.1 Million | USD 799.7 Million | 11.6% |
China Bioinformatics Market
The China bioinformatics market was valued at USD 1,193.8 million in 2026 and is projected to reach USD 2,400.2 million by 2031, representing a CAGR of 15.0%.
China’s bioinformatics market is positioned for sustained growth, driven by government support for precision medicine initiatives and increased healthcare digitalization efforts.
Japan Bioinformatics Market
The Japan bioinformatics market was valued at USD 823.2 million in 2026 and is projected to reach USD 1,606.3 million by 2031, representing a CAGR of 14.3%.
Japan’s bioinformatics market is poised for accelerated growth through 2031, driven by the nation’s commitment to precision medicine and genomic research excellence.
India Bioinformatics Market
The India bioinformatics market was valued at USD 568.3 million in 2026 and is projected to reach USD 1,177.0 million by 2031, representing a CAGR of 15.7%.
India’s bioinformatics market is poised for substantial growth, driven by the country’s emergence as a global leader in genomic research and personalized medicine.
South Korea Bioinformatics Market
The South Korea bioinformatics market was valued at USD 277.9 million in 2026 and is projected to reach USD 518.3 million by 2031, representing a CAGR of 13.3%.
South Korea’s bioinformatics market is poised for substantial growth, expanding from USD 277.9 million in 2026 to USD 518.3 million by 2031.
Australia Bioinformatics Market
The Australia bioinformatics market was valued at USD 342.3 million in 2026 and is projected to reach USD 619.4 million by 2031, representing a CAGR of 12.6%.
Australia’s bioinformatics market is positioned for sustained expansion, driven by increasing government support for genomic research and a growing emphasis on precision healthcare.
Rest of Asia Pacific Bioinformatics Market
The Rest of Asia Pacific bioinformatics market was valued at USD 462.1 million in 2026 and is projected to reach USD 799.7 million by 2031, representing a CAGR of 11.6%.
Rest of Asia Pacific represents a compelling growth opportunity within the broader bioinformatics ecosystem, supported by increasing investments in genomic research, healthcare digitalization, and precision medicine.
Latin America Bioinformatics Market
The Latin America bioinformatics market was valued at USD 931.1 million in 2026 and is projected to reach USD 1,635.8 million by 2031, representing a CAGR of 11.9%.
Latin America’s bioinformatics market is positioned for substantial growth as healthcare systems modernize and invest in digital health infrastructure.
Brazil Bioinformatics Market
The Brazil bioinformatics market was valued at USD 424.7 million in 2026 and is projected to reach USD 780.3 million by 2031, representing a CAGR of 12.9%.
Brazil’s bioinformatics market is positioned for sustained growth through 2031, supported by expanding genomic research initiatives and the rising adoption of personalized medicine across healthcare institutions.
Mexico Bioinformatics Market
The Mexico bioinformatics market was valued at USD 280.1 million in 2026 and is projected to reach USD 487.1 million by 2031, representing a CAGR of 11.7%.
Mexico’s bioinformatics market is poised for significant expansion as healthcare providers increasingly integrate genomic data analytics and personalized medicine into clinical workflows.
Rest of Latin America Bioinformatics Market
The Rest of Latin America bioinformatics market was valued at USD 226.4 million in 2026 and is projected to reach USD 368.4 million by 2031, representing a CAGR of 10.2%.
Rest of Latin America’s bioinformatics market is positioned for steady expansion, driven by increasing healthcare digitalization and growing recognition of genomic medicine’s clinical value.
Middle East Bioinformatics Market
The Middle East bioinformatics market is represented by growing investments in healthcare modernization, genomic research, precision medicine, and digital healthcare infrastructure. The GCC Countries bioinformatics market was valued at USD 272.3 million in 2026 and is projected to reach USD 463.2 million by 2031, representing a CAGR of 11.2%.
GCC Countries Bioinformatics Market
The GCC Countries bioinformatics market was valued at USD 272.3 million in 2026 and is projected to reach USD 463.2 million by 2031, representing a CAGR of 11.2%.
The bioinformatics market in GCC Countries is poised for sustained expansion driven by government-backed healthcare modernization initiatives and increased R&D spending in genomics.
Saudi Arabia Bioinformatics Market
The Saudi Arabia bioinformatics market was valued at USD 134.2 million in 2026 and is projected to reach USD 236.4 million by 2031, representing a CAGR of 12.0%.
Saudi Arabia’s bioinformatics market is poised for substantial expansion as the nation prioritizes healthcare digitalization under Vision 2030.
UAE Bioinformatics Market
The UAE bioinformatics market was valued at USD 95.2 million in 2026 and is projected to reach USD 157.9 million by 2031, representing a CAGR of 10.7%.
The UAE bioinformatics market is poised for significant growth driven by the nation’s strategic focus on healthcare modernization and precision medicine initiatives.
Rest of GCC Bioinformatics Market
The Rest of GCC bioinformatics market was valued at USD 42.9 million in 2026 and is projected to reach USD 68.9 million by 2031, representing a CAGR of 9.9%.
Rest of GCC’s bioinformatics market is positioned for sustained growth as regional healthcare systems increasingly prioritize genomic research and precision medicine initiatives.
Africa Bioinformatics Market
The Africa bioinformatics market is supported by increasing investments in genomic research, personalized medicine, healthcare digitalization, and life sciences infrastructure. The South Africa bioinformatics market was valued at USD 117.5 million in 2026 and is projected to reach USD 186.4 million by 2031, representing a CAGR of 9.7%.
South Africa Bioinformatics Market
The South Africa bioinformatics market was valued at USD 117.5 million in 2026 and is projected to reach USD 186.4 million by 2031, representing a CAGR of 9.7%.
South Africa’s bioinformatics market is experiencing sustained growth as the nation prioritizes genomic research and personalized medicine within its healthcare system.
Global Bioinformatics Market Outlook
The global bioinformatics market is entering a period of significant expansion, supported by the increasing adoption of NGS technology, AI and machine learning applications, precision medicine, omics research, and cloud-based bioinformatics platforms. The market is projected to grow from USD 18.63 billion in 2026 to USD 34.41 billion by 2031, representing a CAGR of 13.1%.
North America and Europe continue to benefit from established pharmaceutical, biotechnology, and genomic research ecosystems, while Asia Pacific demonstrates strong growth potential through increasing investments in precision medicine, healthcare digitalization, and genomic research infrastructure.
Latin America and the Middle East are also creating opportunities as healthcare systems modernize and investments in genomic medicine and digital health increase. Across markets, the growing need to manage large volumes of biological data is expected to support continued adoption of bioinformatics solutions.
As pharmaceutical and biotechnology companies increasingly integrate bioinformatics into drug discovery, biomarker detection, clinical trials, genomic analysis, and precision medicine, technological innovation and advanced data analytics are expected to remain central to the market’s development through 2031.
